p16INK4a as a tumor suppressor with therapeutic applicability

被引：2

作者：

Calbó, J ^{[1
]}

Mazo, A ^{[1
]}

机构：

[1] Univ Barcelona, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain

来源：

DRUGS OF THE FUTURE | 2003年 / 28卷 / 02期

关键词：

D O I：

10.1358/dof.2003.028.02.856928

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The p16(INK4a/ARF) locus encodes for 2 tumor suppressor genes commonly lost during transformation and acquisition of malignancy processes. The product of p16(INK4a) gene is a CDK inhibitor that constrains cell cycle progression in response to different proliferative stresses and participates in cell-environment signaling pathways. Restitution of p16/(INK4a) function has showed potent antitumoral activity in new gene therapy approaches and should be taken into consideration for future design of rationale and specific therapeutic strategies against cancer.

引用

页码：153 / 166

页数：14

共 151 条

[1] RETRACTED: Down-regulation of integrin αvβ3 expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes (Retracted article. See vol. 295, pg. 13134, 2020) [J].

Adachi, Y ;

Lakka, SS ;

Chandrasekar, N ;

Yanamandra, N ;

Gondi, CS ;

Mohanam, S ;

Dinh, DH ;

Olivero, WC ;

Gujrati, M ;

Tamiya, T ;

Ohmoto, T ;

Kouraklis, G ;

Aggarwal, B ;

Rao, JS .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (50) :47171-47177

[2] Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences [J].

Adachi, Y ;

Chandrasekar, N ;

Kin, Y ;

Lakka, SS ;

Mohanam, S ;

Yanamandra, N ;

Mohan, PM ;

Fuller, GN ;

Fang, BL ;

Fueyo, J ;

Dinh, DH ;

Olivero, WC ;

Tamiya, T ;

Ohmoto, T ;

Kyritsis, AP ;

Rao, JS .

ONCOGENE, 2002, 21 (01) :87-95

[3] Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a [J].

Alani, RM ;

Young, AZ ;

Shifflett, CB .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (14) :7812-7816

[4] Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts [J].

Alcorta, DA ;

Xiong, Y ;

Phelps, D ;

Hannon, G ;

Beach, D ;

Barrett, JC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :13742-13747

[5] Cyclin E and c-Myc promote cell proliferation in the presence of p16(INK4a) and of hypophosphorylated retinoblastoma family proteins [J].

Alevizopoulos, K ;

Vlach, J ;

Hennecke, S ;

Amati, B .

EMBO JOURNAL, 1997, 16 (17) :5322-5333

[6] Adenovirus p16 gene therapy for prostate cancer [J].

Allay, JA ;

Steiner, MS ;

Zhang, Y ;

Reed, CP ;

Cockroft, J ;

Lu, Y .

WORLD JOURNAL OF UROLOGY, 2000, 18 (02) :111-120

[7] Functional analysis of wild-type and malignant glioma derived CDKN2A beta alleles: Evidence for an RB-independent growth suppressive pathway [J].

Arap, W ;

Knudsen, E ;

Sewell, DA ;

Sidransky, D ;

Wang, JYJ ;

Huang, HJS ;

Cavenee, WK .

ONCOGENE, 1997, 15 (17) :2013-2020

[8]

Bai JX, 2001, CHINESE MED J-PEKING, V114, P497

[9]

Bai X, 2000, Zhonghua Bing Li Xue Za Zhi, V29, P354

[10]

Bender CM, 1998, CANCER RES, V58, P95

← 1 2 3 4 5 6 7 8 9 10 →